Koichi Furukawa

50595202, Oct 22, 1991

Aug 27, 1986

6/900820

Koichi Furukawa - New York NY
Hanrik Clausen - Seattle WA
Sen-itiroh Hakomori - Seattle WA
Junichi Sakamoto - Nagoya, JP
Katherine Look - New York NY
M. Jules Mattes - Flushing NY
Lloyd Kenneth O. - Bronx NY

Sloan-Kettering Institute for Cancer Research - New York NY

G01N 3353
G01N 33577
C07K 1514
C12N 100

435 721

Monoconal antibodies HT29-36, CB, CLH6, M2, and S12 are useful in determining the presence of Type A blood group antigen and in distinguishing different forms of this antigen. As type A antigen exhibits several forms differing in minor respects only, the monoclonal antibodies are useful in making fine distinctions between the different forms, and may be used, e. g. , in cancer diagnosis, and the like.

50064703, Apr 9, 1991

Apr 16, 1987

7/039479

Hiroshi Yamaguchi - Bronx NY
Koichi Furukawa - New York NY
Philip O. Livingston - New York NY
Kenneth O. Lloyd - Bronx NY
Herbert F. Oettgen - New Canon CT
Lloyd J. Old - New York NY
Sheila R. Fortunato - Hollis NY

Sloan-Kettering Institute for Cancer Research - New York NY

C12N 512
C07K 1528
A61K 3900
G01N 3353

424 858

This invention provides a monoclonal antibody, produced by the hybridoma cell line designated GXM1, which specifically binds to a human class 1tumor antigen. This invention also provides a human monoclonal antibody, produced by a hybridoma cell line designated HJM1, which specifically binds to each of the ganglioside antigens GD2, GD3, GM3 and GD1b. This invention further provides a human monoclonal antibody, produced by a hybridoma cell line designated FCM1, which specifically binds to the ganglioside antigens GM3 and GD1a. Finally, this invention provides a human monoclonal antibody, produced by a hybridoma cell line designated DSM1, which specifically binds to a human class 2 tumor protein antigen.